Methylglyoxal (MG) Competitive ELISA

Methylglyoxal (MG) Competitive ELISA
  • Rapid detection and quantitation of MG-H1 (methyl-glyoxal-hydro-imidazolone) protein adducts
  • Provides sufficient reagents to perform up to 96 assays, including standard curve and unknown protein samples

 

Frequently Asked Questions about this product

General FAQs about Oxidative Stress

Email To BuyerPrint this PageCopy Link
Ordering

Please contact your distributor for pricing.

OxiSelect™ Methylglyoxal (MG) Competitive ELISA Kit
Catalog Number
STA-811
Size
96 assays
Detection
Colorimetric
Manual/Data Sheet Download
SDS Download
Price
$755.00
OxiSelect™ Methylglyoxal (MG) Competitive ELISA Kit
Catalog Number
STA-811-5
Size
5 x 96 assays
Detection
Colorimetric
Manual/Data Sheet Download
SDS Download
Price
$3,250.00
Product Details

The OxiSelect™ Methylglyoxal (MG) ELISA Kit is an enzyme immunoassay developed for rapid detection and quantitation of MG-H1 (methyl-glyoxal-hydro-imidazolone) protein adducts.  The quantity of MG adduct in protein samples is determined by comparing its absorbance with that of a known MG-BSA standard curve.  Each kit provides sufficient reagents to perform up to 96 assays, including standard curve and unknown protein samples.

Recent Product Citations
  1. Swanson, M.A. et al. (2026). A Nonketotic Hyperglycinemia Mouse Shows Wide-Ranging Biochemical Consequences of Elevated Glycine, Reduced Folate One-Carbon Charging, and Serine Deficiency. J Inherit Metab Dis. 49(1):e70137. doi: 10.1002/jimd.70137.
  2. Manfredelli, D. et al. (2025). PTEN/PKM2/ERα-Driven Glyoxalase 1 Overexpression Sustains PC3 Prostate Cancer Cell Growth Through MG-H1/RAGE Pathway Desensitization Leading to H2O2-Dependent KRIT1 Downregulation. Antioxidants. 14(9):1120. doi: 10.3390/antiox14091120.
  3. Pulkkinen, M.A. et al. (2025). Skeletal health in adolescents with poorly controlled type 1 diabetes: results from a randomized controlled trial. BMJ Open Diabetes Res Care. 13(5):e005134. doi: 10.1136/bmjdrc-2025-005134.
  4. Song, J. et al. (2025). Exploration and analysis of methylglyoxal-driven chronic inflammation in polycystic ovary syndrome. J Adv Res. doi: 10.1016/j.jare.2025.08.048.
  5. Soldavini, C.M. et al. (2025). Gestational diabetes severity stratification during pregnancy: role of plasma oleic acid as a possible early marker. Acta Diabetol. doi: 10.1007/s00592-025-02487-2.
  6. Damasiewicz-Bodzek, A. et al. (2025). Low Serum Methylglyoxal Levels Correlate with Psoriasis Severity and Inflammatory Response Indices. Pathophysiology. 32(1):8. doi: 10.3390/pathophysiology32010008.
  7. Cho, C.H. et al. (2025). Ishophloroglucin A Isolated from Ishige okamurae Protects Glomerular Cells from Methylglyoxal-Induced Diacarbonyl Stress and Inhibits the Pathogenesis of Diabetic Nephropathy. Mar Drugs. 23(1):48. doi: 10.3390/md23010048.
  8. Gutierrez-Mariscal, F.M. et al. (2024). Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trial. Cardiovasc Diabetol. 23(1):361. doi: 10.1186/s12933-024-02451-4.
  9. Adeshara, K. et al. (2024). Protein glycation products associate with progression of kidney disease and incident cardiovascular events in individuals with type 1 diabetes. Cardiovasc Diabetol. 23(1):235. doi: 10.1186/s12933-024-02316-w.
  10. Gutierrez-Mariscal, F.M. et al. (2024). Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV randomized controlled trial. Diabetes Metab. 50(1):101503. doi: 10.1016/j.diabet.2023.101503.
  11. Nakamura, T. et al. (2023). Continuous low serum levels of advanced glycation end products and low risk of cardiovascular disease in patients with poorly controlled type 2 diabetes. Cardiovasc Diabetol. 22(1):147. doi: 10.1186/s12933-023-01882-9.
  12. Al-Robaiy, S. et al. (2022). RAGE-Dependent Effect of Exogenous Methylglyoxal Intake on Lung Biomechanics in Mice. Nutrients. 15(1):23. doi: 10.3390/nu15010023.
  13. Kim, H.J. et al. (2022). Vitamin A aldehyde-taurine adducts function in photoreceptor cells. Redox Biol. doi: 10.1016/j.redox.2022.102386.
  14. Yang, S.E. et al. (2022). Insulin sensitizer and antihyperlipidemic effects of Cajanus cajan (L.) millsp. root in methylglyoxal-induced diabetic rats. Chin J Physiol. 65(3):125-135. doi: 10.4103/cjp.cjp_88_21.
  15. Tisi, A. et al. (2022). Antioxidant Properties of Cerium Oxide Nanoparticles Prevent Retinal Neovascular Alterations In Vitro and In Vivo. Antioxidants. 11(6):1133. doi: 10.3390/antiox11061133.
  16. Oliveira, A.L. et al. (2022). Enhanced RAGE Expression and Excess Reactive-Oxygen Species Production Mediates Rho Kinase-Dependent Detrusor Overactivity After Methylglyoxal Exposure. Front Physiol. doi: 10.3389/fphys.2022.860342.
  17. Maciejczyk, M. et al. (2022). Oxidation, Glycation, and Carbamylation of Salivary Biomolecules in Healthy Children, Adults, and the Elderly: Can Saliva Be Used in the Assessment of Aging? J Inflamm Res. 15:2051-2073. doi: 10.2147/JIR.S356029.
  18. Santini, S.J. et al. (2022). Copper-catalyzed dicarbonyl stress in NAFLD mice: protective effects of Oleuropein treatment on liver damage. Nutr Metab (Lond). 19(1):9. doi: 10.1186/s12986-022-00641-z.
  19. Krisanits, B.A. et al. (2022). Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblasts. Transl Oncol. 17:101350. doi: 10.1016/j.tranon.2022.101350.
  20. Kim, M. et al. (2021). Anti-glycation effect and renal protective activity of Colpomenia sinuosa extracts against advanced glycation end-products (AGEs). J. Mar. Biosci. Biotechnol. 13(2):94-103. doi: 10.15433/ksmb.2021.13.2.094.
  21. Medeiros, M.L. et al. (2021). Methylglyoxal Exacerbates Lipopolysaccharide-Induced Acute Lung Injury via RAGE-Induced ROS Generation: Protective Effects of Metformin. J Inflamm Res. 14:6477-6489. doi: 10.2147/JIR.S337115.
  22. Pantner, Y. et al. (2021). DJ-1 attenuates the glycation of mitochondrial complex I and complex III in the post-ischemic heart. Sci Rep. 11(1):19408. doi: 10.1038/s41598-021-98722-1.
  23. Oliveira, A.L. et al. (2021). Metformin abrogates the voiding dysfunction induced by prolonged methylglyoxal intake. Eur J Pharmacol. 910:174502. doi: 10.1016/j.ejphar.2021.174502.
  24. Kim, M. et al. (2021). Ishige okamurae Ameliorates Methylglyoxal-Induced Nephrotoxicity via Reducing Oxidative Stress, RAGE Protein Expression, and Modulating MAPK, Nrf2/ARE Signaling Pathway in Mouse Glomerular Mesangial Cells. Foods. 10(9):2000. doi: 10.3390/foods10092000.
  25. Ragno, V.M. et al. (2021). Morphometric, metabolic, and inflammatory markers across a cohort of client-owned horses and ponies on the insulin dysregulation spectrum. J Equine Vet Sci. doi: 10.1016/j.jevs.2021.103715.
  26. Suh, K.S. et al. (2021). Protective effects of sciadopitysin against methylglyoxal-induced degeneration in neuronal SK-N-MC cells. J Appl Toxicol. doi: 10.1002/jat.4211.
  27. Gutierrez-Mariscal, F.M. et al. (2020). Reduction in Circulating Advanced Glycation End Products by Mediterranean Diet is Associated with Increased Likelihood of type 2 Diabetes Remission in Patients with Coronary Heart Disease: From the Cordioprev Study. Mol Nutr Food Res. doi: 10.1002/mnfr.201901290.
  28. Li, J. et al. (2020). Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules. JCI Insight. pii: 129034. doi: 10.1172/jci.insight.129034.
  29. Piuri, G. et al. (2020). Methylglyoxal, Glycated Albumin, PAF, and TNF-α: Possible Inflammatory and Metabolic Biomarkers for Management of Gestational Diabetes. Nutrients. 12:479. doi: 10.3390/nu12020479.
  30. Shimizu, Y. et al. (2020). Role of DJ‐1 in Modulating Glycative Stress in Heart Failure. J Am Heart Assoc. 9(4). doi: 10.1161/jaha.119.014691.